A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer

Date Added
January 10th, 2012
PRO Number
Pro00015069
Researcher
Megan Ruppel

List of Studies

Keywords
Cancer, Cancer/Breast
Summary

The purpose of this study is to compare the good and bad effects of a new approach that includes surgery plus radiation for the tumor in your breast to the standard approach of continued treatment with the medication which is working to control your tumor.

Institution
MUSC
Recruitment Contact
Katherine Halloran
843-792-7035
halloran@musc.edu

A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications

Date Added
August 16th, 2011
PRO Number
Pro00011805
Researcher
Michelle Hudspeth

List of Studies


Keywords
Cancer, Children's Health, Men's Health, Minorities, Pediatrics, Transplant, Women's Health
Summary

The primary purposes of this study are to:
•Provide access to cord blood units for recipients whose best choice for a cord blood unit(s) do not meet all FDA standards, but do meet standards set by the NMDP on this study.
•Assess how well and how quickly blood counts return to normal after transplant in recipients on this study.

Institution
MUSC
Recruitment Contact
HCC Clinical Trials Office
843-792-9321
hcc-clinical-trials@musc.edu

Human Aortic Tissue Analysis in Health and Disease

Date Added
June 17th, 2008
PRO Number
Pro00125518
Researcher
Jeffrey Jones

List of Studies


Keywords
Cardiovascular
Summary

Patients diagnosed with an enlarged aorta (aneurysm) or separation of the layers of the aorta (dissection) can suffer complications. The purpose of this study is to determine the levels of proteins and their effects on the aortic tissue wall.

Institution
MUSC
Recruitment Contact
Lauren Wakefield
8438765049
wakefila@musc.edu

Contegra Pulmonary Valved Conduit, Model 200 and 200S (HDE)

Date Added
July 20th, 2004
PRO Number
Pro00143036
Researcher
Scott Bradley

List of Studies


Keywords
Heart
Summary

HUD. The objectives of this study are to evaluate the safety and efficacy of the Contegra® valved conduit for
reconstruction or replacement of the natural right ventricular outflow tract (RVOT) or replacement of
a failed homograft or composite pulmonary conduit in patients under 18 years of age.

Institution
MUSC
Recruitment Contact
Scott Bradley
843-792-3361
bradlesm@musc.edu

Protocol for a Research Database for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Date Added
December 17th, 2002
PRO Number
Pro00136123
Researcher
Michelle Hudspeth

List of Studies


Keywords
Adolescents, Cancer, Transplant
Summary

The Center for International Blood and Marrow Transplant Research (CIBMTR ) keeps a research database. It uses this database to collect and study the medical data for patients that have received Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries. It also collects and studies data from donors who give bone marrow or peripheral blood stem cells (PBSCs). These therapies are used to treat cancer and other diseases. The purpose of this study is to add more data to the database. Participants will have medical data (data about their disease, transplant or cellular therapy) collected before and after transplant cellular therapy, and once a year afterwards for life.

Institution
MUSC
Recruitment Contact
HCC Clinical Trials Office
843-792-9321
hcc-clinical-trials@musc.edu

Protocol for a Research Sample Repository for Allogeneic Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Date Added
December 17th, 2002
PRO Number
Pro00136076
Researcher
Michelle Hudspeth

List of Studies


Keywords
Adolescents, Cancer, Transplant
Summary

The primary purpose of the Research Sample Repository is to make blood samples available for research studies related to histocompatibility and hematopoietic cell transplantation (HCT) or other cellular therapy.

Institution
MUSC
Recruitment Contact
HCC Clinical Trials Office
843-792-9321
hcc-clinical-trials@musc.edu

Cystic Fibrosis Patient Registry

Date Added
December 9th, 2002
PRO Number
Pro00120872
Researcher
Patrick Flume

List of Studies


Keywords
Cystic Fibrosis
Summary

The CF Patient Registry is an observational study. It does not involve medical treatments and serves only as an epidemiologic record of demographics, characteristics of disease and treatment, utilization patterns, and clinical outcomes.

Institution
MUSC
Recruitment Contact
Zerlinna Teague
8437920965
recruitment@musc.edu



-- OR --